Personal information

腫瘤免疫治療, 乳癌幹細胞生物學, Cancer immunotherapy, Breast cancer stem cell biology, NKT-stimulatory glycolipids as anti-cancer agents and vaccine adjuvants

Activities

Employment (6)

Institute of Stem Cell and Translational Cancer Research, Linkou Chang Gung Memorial Hospital: Linkou, TW

2013-06-01 to present | Distinguished Chair Professor and Co-Director
Employment
Source: Self-asserted source
alice yu

Chang Gung University: Kwei-Shan, Taoyuan, TW

2013-06-01 to present (Distinguished Chair Professor)
Employment
Source: Self-asserted source
alice yu

Genomics Research Center Academia Sinica: Taipei, TW

2013 to present | Distinguished Visiting Fellow
Employment
Source: Self-asserted source
alice yu

University of California San Diego: La Jolla, CA, US

1994 to present | Professor (Pediatrics)
Employment
Source: Self-asserted source
alice yu

Genomics Research Center Academia Sinica: Taipei, TW

2003 to 2013 | Distinguished Research Fellow and Associate Director
Employment
Source: Self-asserted source
alice yu

University of California San Diego: La Jolla, CA, US

1977 to 1994 | Assistant Professor to Associate Professor (Pediatrics)
Employment
Source: Self-asserted source
alice yu

Education and qualifications (2)

University of Chicago: Chicago, IL, US

1969 to 1973 | PhD (microbiology & immunology)
Education
Source: Self-asserted source
alice yu

National Taiwan University: Taipei, TW

1961 to 1968 | MD (College of Medicine)
Education
Source: Self-asserted source
alice yu

Funding (6)

Predicting toxicity and success of anti-GD2 immunotherapy of neuroblastoma

2012-04-01 to 2015-03-31 | Grant
National Cancer Institute (Bethesda, US)
GRANT_NUMBER: 5R01CA164132-03
GRANT_NUMBER: 5R01CA164132-03
Source: Self-asserted source
alice yu via DimensionsWizard

IMMUNE MONITOR FOR COG TRIAL OF ANTI-GD2 IN NEUROBLASTOMA

2003-09-30 to 2010-05-31 | Grant
U.S. Food and Drug Administration (Silver Spring, US)
GRANT_NUMBER: 5R01FD002319-05
GRANT_NUMBER: 5R01FD002319-05
Source: Self-asserted source
alice yu via DimensionsWizard

CLINICAL TRIAL OF ANTIID VACCINE FOR NEUROBLASTOMA

1998-07-01 to 2000-06-30 | Grant
National Cancer Institute (Bethesda, US)
GRANT_NUMBER: 5R21CA078806-02
GRANT_NUMBER: 5R21CA078806-02
Source: Self-asserted source
alice yu via DimensionsWizard

EXPLOITATION OF FREQUENT P16 DELETION IN T-ALL THERAPY

1996-04-01 to 1998-03-31 | Grant
National Cancer Institute (Bethesda, US)
GRANT_NUMBER: 5R21CA070397-02
GRANT_NUMBER: 5R21CA070397-02
Source: Self-asserted source
alice yu via DimensionsWizard

CLINICAL UTILITY OF A NEUROBLASTOMA MONOCLONAL ANTIBODY

1985-09-01 to 1988-11-30 | Grant
National Cancer Institute (Bethesda, US)
GRANT_NUMBER: 5R01CA040186-03
GRANT_NUMBER: 5R01CA040186-03
Source: Self-asserted source
alice yu via DimensionsWizard

Identification of Biomarkers for Personalized Immunotherapy of Neuroblastoma

Grant
Congressionally Directed Medical Research Programs (n/a, US)
GRANT_NUMBER:

W81XWH1210427

GRANT_NUMBER: W81XWH1210427
Source: Self-asserted source
alice yu via DimensionsWizard

Peer review (2 reviews for 2 publications/grants)

Review activity for Advanced science. (1)
Review activity for Cell death discovery. (1)